0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA | 
Research Letter | 
Kevin R. Riggs, MD, MPH; Jodi B. Segal, MD, MPH; Eun Ji Shin, MD, PhD; et al.
JAMA. 2016;315(5):514-515. doi:10.1001/jama.2015.15278.

JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
Steven M. Offer, PhD; Robert B. Diasio, MD
JAMA Oncol. Published online January 21, 2016. doi:10.1001/jamaoncol.2015.5463

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Valérie Boige, MD, PhD; Marc Vincent, PhD; Philippe Alexandre, MS; et al.
JAMA Oncol. Published online January 21, 2016. doi:10.1001/jamaoncol.2015.5392
Includes: Supplemental Content

JAMA | 
Original Investigation | 
Alexi A. Wright, MD, MPH; Nancy L. Keating, MD, MPH; John Z. Ayanian, MD, MPP; et al.
JAMA. 2016;315(3):284-292. doi:10.1001/jama.2015.18604.
Includes: CME, Supplemental Content

JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
Dirk Klingbiel, PhD; Sabine Tejpar, MD, PhD
JAMA Oncol. Published online January 14, 2016. doi:10.1001/jamaoncol.2015.5226

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Julien Taieb, MD, PhD; Aziz Zaanan, MD, PhD; Karine Le Malicot, MS; et al.
JAMA Oncol. Published online January 14, 2016. doi:10.1001/jamaoncol.2015.5225
Includes: Supplemental Content

JAMA | 
News From the Centers for Disease Control and Prevention | 
JAMA. 2016;315(2):123. doi:10.1001/jama.2015.17834.

JAMA Surgery | 
Research Letter | 
John T. Killian Jr, MA; Carla N. Holcomb, MD; Laura A. Graham, MPH; et al.
JAMA Surg. 2016;151(1):86-88. doi:10.1001/jamasurg.2015.3130.

JAMA Oncology | 
Editorial | 
Greg Yothers, PhD; Nan Song, PhD; Thomas J. George Jr, MD
JAMA Oncol. 2016;2(1):23-24. doi:10.1001/jamaoncol.2015.3614.

JAMA Oncology | 
Original Investigation | 
Shanwu Gao, MSc; Chabane Tibiche, MSc; Jinfeng Zou, PhD; et al.
JAMA Oncol. 2016;2(1):37-45. doi:10.1001/jamaoncol.2015.3413.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Research Letter  | 
Prevalence and Cost of Office Visits Prior to Colonoscopy for Colon Cancer Screening
Kevin R. Riggs, MD, MPH; Jodi B. Segal, MD, MPH; Eun Ji Shin, MD, PhD; et al.
JAMA Oncology
Invited Commentary  | 
Biomarkers of Fluorouracil Toxicity Insight From the PETACC-8 Trial
Steven M. Offer, PhD; Robert B. Diasio, MD
JAMA Oncology
Original Investigation  | 
DPYD Genotyping to Predict Adverse Events Following Treatment With Flourouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer A Secondary Analysis of the PETACC-8 Randomized Clinical Trial
Valérie Boige, MD, PhD; Marc Vincent, PhD; Philippe Alexandre, MS; et al.
JAMA
Original Investigation  | 
Family Perspectives on Aggressive Cancer Care Near the End of Life
Alexi A. Wright, MD, MPH; Nancy L. Keating, MD, MPH; John Z. Ayanian, MD, MPP; et al.